The Lymphoma Research Foundation thanks Senate leaders for swift action to preserve federal funding of biomedical research conducted through the Department of Defense (DoD). Thanks to the efforts of advocates across the country, the bi-partisan amendment, led by Senator Richard…
New York, NY (April 20, 2016) – The Lymphoma Research Foundation’s Erase Lymphoma initiative hosted a successful briefing on Capitol Hill on Tuesday, March 22, 2016 for members of Congress and U.S. federal policy makers. The briefing entitled, “Tackling the Challenges…
LRF Stands In Support of New National Push Outlined in President Obama’s State of the Union Address to Increase Research Funding in an Effort to Eradicate Cancer On the heels of Tuesday night’s State of the Union address, the Lymphoma…
Lymphoma Research Foundation publishes White Paper to outline key issues discussed during Oral Therapies workshop In September 2015, The Lymphoma Research Foundation (LRF) convened scientists, clinicians, advocates, pharmaceutical industry representatives, and federal lawmakers and regulators for a workshop on Oral…
The Lymphoma Research Foundation (LRF) – the nation’s largest nonprofit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services – today announced its support…
New York, NY (June 15, 2015) – The Lymphoma Research Foundation (LRF) – the nation’s largest nonprofit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and…
The Annual Meeting of the American Society of Hematology (ASH), convened in December 2014, highlighted the expanding array of novel therapy treatments showing promise for non-Hodgkin lymphoma (NHL) patients. Covering a gamut of research from expanded analyses of recently approved…
The Annual Meeting of the American Society of Hematology (ASH), convened in December 2014, highlighted the expanding array of novel therapy treatments showing promise for non-Hodgkin lymphoma (NHL) patients. Covering a gamut of research from expanded analyses of recently approved…
The Annual Meeting of the American Society of Hematology (ASH), convened in December 2014, highlighted the expanding array of novel therapy treatments showing promise for non-Hodgkin lymphoma (NHL) patients. Covering a gamut of research from expanded analyses of recently approved…